Anticardiolipin IgG antibody and homocysteine as possible risk factors for retinal vascular occlusive disease in Thai patients

Japanese Journal of Ophthalmology

Volumn 49, Issue 3, 2005, Pages 211-215

  Atchaneeyasakul, La Ongsri ^a   Trinavarat, Adisak ^a   Bumrungsuk, Parapun ^a   Wongsawad, Warapat ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Anticardiolipin antibody; Homocysteine; Retinal vascular occlusive disease

Indexed keywords

CARDIOLIPIN ANTIBODY; HOMOCYSTEINE; IMMUNOGLOBULIN G ANTIBODY;

ADULT; AGED; AMINO ACID BLOOD LEVEL; ANTIBODY BLOOD LEVEL; ARTICLE; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEMOCONCENTRATION; HUMAN; LABORATORY TEST; MALE; PRIORITY JOURNAL; RETINA BLOOD VESSEL OCCLUSION; RISK FACTOR; STATISTICAL SIGNIFICANCE; THAILAND;

ADOLESCENT; ADULT; AGED; ANTIBODIES, ANTICARDIOLIPIN; FEMALE; HOMOCYSTEINE; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; RETINAL ARTERY OCCLUSION; RETINAL VEIN OCCLUSION; RETROSPECTIVE STUDIES; RISK FACTORS; THAILAND;

EID: 21144437718     PISSN: 00215155     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10384-005-0190-3     Document Type: Article

References (32)

1. Nwosu SN. Prevalence and pattern of retinal diseases at the Guinness Eye Hospital, Onitsha, Nigeria. Ophthalmic Epidemiol 2000;7:41-48.
2. Mitchell P, Smith W, Chang A. Prevalence and associations of retinal vein occlusion in Australia. The Blue Mountains Eye Study. Arch Ophthalmol 1996;114:1243-1247.
3. Hayreh SS, Zimmerman B, McCarthy MJ, Podhajsky P. Systemic diseases associated with various types of retinal vein occlusion. Am J Ophthalmol 2001;131:61-77.
4. Zitouni M, Turki F, Malouche N, et al. Antiphosphoplipid antibodies and retinal occlusive vasculopathy. Ann Biol Clin (Paris) 2002;60:287-291.
5. Greiner K, Peetz D, Winkgen A, Prellwitz W, Pfeiffer N, Hafner G. Genetic thrombophilia in patients with retinal vascular occlusion. Int Ophthalmol 1999;23:155-160.
6. Kuhli C, Hattenbach LO, Scharrer I, Koch F, Ohrloff C. High prevalence of resistance to APC in young patients with retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 2002;240:163-168.
7. Bertram B, Remky A, Arend O, Wolf S, Reim M. Protein C. protein S. and antithrombin III in acute ocular occlusive diseases. Ger J Ophthalmol 1995;4:332-335.
8. Ros MA, Magargal LE, Uram M. Branch retinal-artery obstruction: a review of 201 eyes. Ann Ophthalmol 1989;21:103-107.
9. Greven CM, Slusher MM, Weaver RG. Retinal arterial occlusions in young adults. Am J Ophthalmol 1995;120:776-783.
10. Demirci FY, Kucukkaya R, Akarcay K, et al. Ocular involvement in primary antiphospholipid syndrome. Ocular involvement in primary APS. Int Ophthalmol 1998;22:323-329.
11. Pierangeli SS, Harris EN. Probing antiphospholipid-mediated thrombosis: the interplay between anticardiolipin antibodies and endothelial cells. Lupus 2003;12:539-545.
12. McCully KS. Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am J Pathol 1969;56:111-128.
13. McCully KS, Wilson RB. Homocysteine theory of arteriosclerosis. Atherosclerosis 1975;22:215-227.
14. Biousse V, Newman NJ, Sternberg P Jr. Retinal vein occlusion and transient monocular visual loss associated with hyperhomocystine-mia. Am J Ophthalmol 1997;124:257-260.
15. de Bruijne EL, Keulen-de Vos GH, Ouwendijk RJ. Ocular venous occlusion and hyperhomocysteinemia. Ann Intern Med 1999;130:78.
16. Abu El-Asrar AM, Abdel Gader AG, Al-Amro SA, Al-Attas OS. Hyperhomocysteinemia and retinal vascular occlusive disease. Eur J Ophthalmol 2002;12:495-500.
17. Cahill M, Karabatzaki M, Meleady R, et al. Raised plasma homocysteine as a risk factor for retinal vascular occlusive disease. Br J Ophthalmol 2000;84:154-157.
18. Vine AK. Hyperhomocysteinemia: a risk factor for central retinal vein occlusion. Am J Ophthalmol 2000;129:640-644.
19. Hansen L, Kristensen HL, Bek T, Ingerslev J. Markers of thrombophilia in retinal vein thrombosis. Acta Ophthalmol Scand 2000;78:523-526.
20. Martin SC, Rauz S, Marr JE, Martin N, Jones AF, Dodson PM. Plasma total homocysteine and retinal vascular disease. Eye 2000;14:590-593.
21. Brown BA, Marx JL, Ward TP, et al. Homocysteine: a risk factor for retinal venous occlusive disease. Ophthalmology 2002;109:287-290.
22. Blondel J, Glacet-Bernard A, Bayani N, et al. Retinal vein occlusion and hyperhomocysteinemia. J Fr Ophtalmol 2003;26:249-253.
23. Lahey JM, Kearney JJ, Tune M. Hypercoagulable states and central retinal vein occlusion. Curr Opin Pulm Med 2003;9:385-392.
24. Cahill MT, Stinnett SS, Fekrat S. Meta-analysis of plasma homocysteine, serum folate, serum vitamin B(12), and thermolabile MTHFR genotype as risk factors for retinal vascular occlusive disease. Am J Ophthalmol 2003;136:1136-1150.
25. Yoo JH, Park JE, Hong KP, et al. Moderate hyperhomocyst(e)inemia is associated with the presence of coronary artery disease and the severity of coronary atherosclerosis in Koreans. Thromb Res 1999;94:45-52.
26. Okada E, Oida K, Tada H, et al. Hyperhomocysteinemia is a risk factor for coronary arteriosclerosis in Japanese patients with type 2 diabetes. Diabetes Care 1999;22:484-490.
27. Joubran R, Asmi M, Busjahn A, Vergopoulos A, Luft FC, Jouma M. Homocysteine levels and coronary heart disease in Syria. J Cardiovasc Risk 1998;5:257-261.
28. Verhoef P, Pasman WJ, Van Vliet T, Urgert R. Katan MB. Contribution of caffeine to the homocysteine-raising effect of coffee: a randomized controlled trial in humans. Am J Clin Nutr 2002;76:1244-1248.
29. Mennen LI, de Courcy GP, Guilland JC, et al. Relation between homocysteine concentrations and the consumption of different types of alcoholic beverages: the French Supplementation with Antioxidant Vitamins and Minerals Study. Am J Clin Nutr 2003;78:334-338.
30. Sobczak AJ. The effects of tobacco smoke on the homocysteine level - a risk factor of atherosclerosis. Addict Biol 2003;8:147-158.
31. Stanger O, Herrmann W, Pietrzik K, et al. DACH-LIGA homocystein (German, Austrian and Swiss Homocysteine Society): consensus paper on the rational clinical use of homocysteine, folic acid and B-vitamins in cardiovascular and thrombotic diseases: guidelines and recommendations. Clin Chem Lab Med 2003;41:1392-1403.
32. de Bree A, Verschuren WM, Blom HJ, Kromhout D. Lifestyle factors and plasma homocysteine concentrations in a general population sample. Am J Epidemiol 2001;154:150-154.